WUXI BIOLOGICS (CAYMAN) INCWUXI BIOLOGICS (CAYMAN) INCWUXI BIOLOGICS (CAYMAN) INC

WUXI BIOLOGICS (CAYMAN) INC

No trades
See on Supercharts
Market capitalization
‪55.54 B‬HKD
‪3.76 B‬HKD
‪18.82 B‬HKD
‪3.07 B‬
Beta (1Y)
1.38

About WUXI BIOLOGICS (CAYMAN) INC

CEO
Zhi Sheng Chen
Headquarters
Wuxi
Employees (FY)
‪12.74 K‬
Founded
2014
ISIN
KYG970081173
FIGI
BBG00GTY47H0
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. Its products include antibody drugs, biological medicines, and other tablets, as well as provides research material generation, sterility assurance programs, clinical trials, and translational oncology research services. The company was founded on February 27, 2014 and is headquartered in Wuxi, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 2269 is 13.24 HKD — it has decreased by 0.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange WUXI BIOLOGICS (CAYMAN) INC stocks are traded under the ticker 2269.
WUXI BIOLOGICS (CAYMAN) INC is going to release the next earnings report on Aug 19, 2024. Keep track of upcoming events with our Earnings Calendar.
2269 stock is 4.92% volatile and has beta coefficient of 1.38. Check out the list of the most volatile stocks — is WUXI BIOLOGICS (CAYMAN) INC there?
One year price forecast for WUXI BIOLOGICS (CAYMAN) INC has a max estimate of 62.90 HKD and a min estimate of 12.00 HKD.
2269 earnings for the last quarter are 0.70 HKD whereas the estimation was 0.59 HKD which accounts for 18.18% surprise. Estimated earnings for the next quarter are 0.28 HKD. See more details about WUXI BIOLOGICS (CAYMAN) INC earnings.
WUXI BIOLOGICS (CAYMAN) INC revenue for the last quarter amounts to ‪9.18 B‬ HKD despite the estimated figure of ‪8.80 B‬ HKD. In the next quarter revenue is expected to reach ‪9.23 B‬ HKD.
Yes, you can track WUXI BIOLOGICS (CAYMAN) INC financials in yearly and quarterly reports right on TradingView.
2269 stock has fallen by 5.83% compared to the previous week, the month change is a 6.63% fall, over the last year WUXI BIOLOGICS (CAYMAN) INC has showed a 75.62% decrease.
2269 net income for the last quarter is ‪1.22 B‬ HKD, while the quarter before that showed ‪2.56 B‬ HKD of net income which accounts for −52.25% change. Track more WUXI BIOLOGICS (CAYMAN) INC financial stats to get the full picture.
Today WUXI BIOLOGICS (CAYMAN) INC has the market capitalization of ‪56.73 B‬, it has decreased by 0.84% over the last week.
No, 2269 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2269 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WUXI BIOLOGICS (CAYMAN) INC stock right from TradingView charts — choose your broker and connect to your account.
2269 reached its all-time high on Jul 2, 2021 with the price of 148.00 HKD, and its all-time low was 8.34 HKD and was reached on Jun 13, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪12.74 K‬ employees. See our rating of the largest employees — is WUXI BIOLOGICS (CAYMAN) INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WUXI BIOLOGICS (CAYMAN) INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WUXI BIOLOGICS (CAYMAN) INC stock shows the sell signal. See more of WUXI BIOLOGICS (CAYMAN) INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on WUXI BIOLOGICS (CAYMAN) INC future price: according to them, 2269 price has a max estimate of 62.90 HKD and a min estimate of 12.01 HKD. Read a more detailed WUXI BIOLOGICS (CAYMAN) INC forecast: see what analysts think of WUXI BIOLOGICS (CAYMAN) INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WUXI BIOLOGICS (CAYMAN) INC EBITDA is ‪5.90 B‬ HKD, and current EBITDA margin is 31.22%. See more stats in WUXI BIOLOGICS (CAYMAN) INC financial statements.